Impact of Consumer Fees on Drug Utilisation

PharmacoEconomics

Volumn 2, Issue 4, 1992, Pages 335-342

  Smith, Dean G ^a   Kirking, Duane M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; DRUG UTILIZATION; ECONOMICS; FEE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; SOCIOECONOMICS;

AGED; DRUG UTILIZATION; HEALTH EXPENDITURES; HUMAN; INSURANCE, PHARMACEUTICAL SERVICES; PRESCRIPTION FEES; SOCIOECONOMIC FACTORS;

EID: 0026935329     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/00019053-199202040-00008     Document Type: Review

References (63)

1. The elderly and drug policy: coming of age
2. Employer sponsored prescription drug benefits
3. Do patients cash prescriptions? An audit of one practice
4. Using survey data to estimate prescription drug costs
5. The demand for health insurance and health care: a review of the empirical literature
6. Inherent risk and market acceptance of generic drug products
7. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly
8. Intentional prescription non-adherence (noncompliance) by the elderly
9. Employer health care plan design and its effect on plan costs
10. The effect of free care on the use of antibiotics: results from a population-based randomized control trial
11. Drug use economics: prescription and nonprescription drug use
12. Indemnity plans turning to mail order, cards
13. The card that failed by doubling Rx use
14. Pharmacy benefits in health maintenance organizations
15. Medicaid patients’ access to new drugs
16. AIDS drugs and the pharmaceutical industry: a need for reform
17. The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization
18. Examining the drug utilization and expenditures of a medically indigent population
19. An analysis of research on mail order pharmacy services
20. Choices in prescription-drug benefit programs: mail versus community pharmacy services
21. Influence of age, sex, and race on prescription drug use among Georgia Medicaid recipients
22. Expanding Medicaid drug formulary coverage: effects on utilization of related services
23. Prescription charges, the demand for prescriptions and morbidity
24. Prescription drugs, practicing physicians, and the elderly
25. Substitution between prescribed and over-the-counter medications
26. The demand for prescription drugs as a function of cost-sharing
27. Prescription cost sharing: economic and health impacts, and implications
28. Subsidizing pharmaceutical prescriptions: the experience of Denmark, Finland, Norway and Sweden
29. The impact of outpatient drug benefits on the use and costs of health care services for the elderly
30. Use of medical care in the Rand health insurance experiment: diagnosis- and service-specific analyses in a randomized control trial
31. Health insurance and the demand for medical care
32. The effect of a Medicaid drug copayment program on the utilization and cost of prescription services
33. Influenza vaccination: Knowledge, attitudes and behavior among high risk outpatients
34. The effect of patient charges on the utilisation of prescription medicines
35. Output and inflation components of medical care and other spending changes
36. Perspectives on compliance with drug regimens among the elderly
37. Copayments for ambulatory care: penny-wise and pound foolish
38. Charging for health care: evidence on the utilisation of NHS prescribed drugs
39. Scottish general practitioners attitudes and knowldege in respect to prescribing costs
40. Trends in retail prescription expenditures
41. Options allow employer to trim drug costs
42. Projections of national health expenditures through the year 2000
43. Payment restrictions for prescription drugs under Medicaid: effects on therapy, cost, and equity
44. Effects of medicaid drug payment limits on admission to hospitals and nursing homes
45. Withdrawing payment for nonscientific drug therapy: intended and unexpected effects of a large-scale natural experiment
46. Patterns of outpatient prescription drug use among Pennsylvania elderly
47. Presciption drug coverage
48. Outpatient prescription drug spending by the Medicare population
49. Legalizing drugs: lessons from (and about) economics
50. Impact of managed care on prescription drug use
51. Health status, sociodemographic factors and the use of prescribed psychotropic drugs
52. Awareness of drug costs among general practitioner trainees
53. Gender, employment and medication use